Asset Management One’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.5M Sell
930,822
-31,054
-3% -$1.81M 0.17% 106
2025
Q4
$52M Sell
961,876
-4,438
-0.5% -$214K 0.14% 121
2025
Q3
$43.6M Sell
966,314
-9,711
-1% -$454K 0.13% 143
2025
Q2
$45.2M Buy
976,025
+39,965
+4% +$1.96M 0.14% 135
2025
Q1
$57.1M Buy
936,060
+46,208
+5% +$2.69M 0.2% 101
2024
Q4
$51.3M Sell
889,852
-6,666
-0.7% -$372K 0.18% 105
2024
Q3
$46.4M Sell
896,518
-29,307
-3% -$1.37M 0.17% 114
2024
Q2
$38.4M Sell
925,825
-45,601
-5% -$2.04M 0.15% 124
2024
Q1
$52.7M Sell
971,426
-64,161
-6% -$3.27M 0.2% 95
2023
Q4
$53M Sell
1,035,587
-82,118
-7% -$4.31M 0.21% 90
2023
Q3
$64.9M Sell
1,117,705
-54,023
-5% -$3.31M 0.29% 64
2023
Q2
$74.9M Sell
1,171,728
-32,479
-3% -$2.18M 0.32% 59
2023
Q1
$83.5M Buy
1,204,207
+12,140
+1% +$856K 0.38% 46
2022
Q4
$85.9M Buy
1,192,067
+65,127
+6% +$4.91M 0.42% 41
2022
Q3
$80.1M Sell
1,126,940
-2,482
-0.2% -$180K 0.41% 43
2022
Q2
$87M Sell
1,129,422
-27,904
-2% -$2.13M 0.41% 45
2022
Q1
$84.5M Buy
1,157,326
+2,738
+0.2% +$184K 0.33% 54
2021
Q4
$71.9M Sell
1,154,588
-16,073
-1% -$943K 0.25% 76
2021
Q3
$69.3M Sell
1,170,661
-19,977
-2% -$1.32M 0.27% 72
2021
Q2
$79.6M Sell
1,190,638
-30,630
-3% -$2M 0.3% 67
2021
Q1
$77.1M Sell
1,221,268
-36,040
-3% -$2.24M 0.31% 65
2020
Q4
$77.3M Buy
1,257,308
+32,515
+3% +$2M 0.32% 62
2020
Q3
$73.8M Sell
1,224,793
-27,372
-2% -$1.65M 0.34% 56
2020
Q2
$73.6M Sell
1,252,165
-84,408
-6% -$5.05M 0.36% 53
2020
Q1
$74.5M Buy
1,336,573
+11,864
+0.9% +$725K 0.44% 46
2019
Q4
$85M Buy
1,324,709
+383,715
+41% +$22M 0.38% 46
2019
Q3
$47.7M Buy
940,994
+15,397
+2% +$724K 0.23% 90
2019
Q2
$42M Sell
925,597
-8,426
-0.9% -$392K 0.21% 95
2019
Q1
$44.6M Sell
934,023
-1,795,762
-66% -$89.5M 0.24% 86
2018
Q4
$142M Buy
2,729,785
+49,462
+2% +$2.66M 0.34% 63
2018
Q3
$166M Buy
2,680,323
+12,035
+0.5% +$714K 0.34% 61
2018
Q2
$148M Buy
2,668,288
+38,457
+1% +$2.08M 0.32% 65
2018
Q1
$166M Buy
2,629,831
+8,654
+0.3% +$557K 0.37% 53
2017
Q4
$161M Sell
2,621,177
-4,148
-0.2% -$259K 0.35% 54
2017
Q3
$167M Sell
2,625,325
-7,149
-0.3% -$417K 0.39% 52
2017
Q2
$147M Sell
2,632,474
-724
-0% -$39.4K 0.37% 53
2017
Q1
$143M Sell
2,633,198
-229,311
-8% -$12.6M 0.38% 51
2016
Q4
$167M Buy
2,862,509
+2,313,897
+422% +$127M 0.43% 46
2016
Q3
$29.6M Sell
548,612
-52,991
-9% -$3.4M 0.44% 46
2016
Q2
$44M Buy
601,603
+36,768
+7% +$2.6M 0.66% 21
2016
Q1
$35.8M Buy
564,835
+35,297
+7% +$2.23M 0.52% 32
2015
Q4
$36.9M Buy
529,538
+5,397
+1% +$357K 0.55% 31
2015
Q3
$30.9M Sell
524,141
-30,176
-5% -$1.91M 0.47% 36
2015
Q2
$36.6M Sell
554,317
-71,607
-11% -$4.72M 0.51% 30
2015
Q1
$41.1M Buy
625,924
+5,818
+0.9% +$364K 0.51% 30
2014
Q4
$37.1M Buy
620,106
+104,666
+20% +$5.9M 0.48% 30
2014
Q3
$26.6M Buy
515,440
+187,051
+57% +$9.34M 0.37% 51
2014
Q2
$16.1M Sell
328,389
-52,100
-14% -$2.57M 0.24% 96
2014
Q1
$19.7M Sell
380,489
-19,808
-5% -$1.05M 0.31% 72
2013
Q4
$21.3M Sell
400,297
-57,649
-13% -$2.94M 0.33% 61
2013
Q3
$21.2M Sell
457,946
-30,369
-6% -$1.33M 0.32% 72
2013
Q2
$22.6M Buy
+488,315
New +$21.2M 0.37% 65

Other funds holding BMY

Asset Management One's BMY Position: Q1 2026 in Review

Asset Management One reduced its Bristol-Myers Squibb (BMY) stake by 3.2% in Q1 2026, selling an estimated $1.81M and leaving 930,822 shares worth $56.5M. The position accounts for 0.17% of the portfolio, ranked #106.

Asset Management One first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $167M in Q4 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Asset Management One held 930,822 shares of Bristol-Myers Squibb worth $56.5M as of Q1 2026.
  • Asset Management One sold 31,054 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.81M.
  • Bristol-Myers Squibb made up 0.17% of Asset Management One's portfolio in Q1 2026, its #106 holding.
  • Asset Management One first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Asset Management One's Bristol-Myers Squibb position peaked at $167M in Q4 2016.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Asset Management One's 13F filing for Q1 2026, filed 8 May 2026.